Federated Hermes’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,081
| Closed | -$10.6K | – | 2263 |
|
|
2023
Q1 | $10.6K | Sell |
7,081
-9,630
| -58% | -$14.4K | ﹤0.01% | 1871 |
|
|
2022
Q4 | $16.7K | Buy |
16,711
+1,635
| +11% | +$1.63K | ﹤0.01% | 1821 |
|
|
2022
Q3 | $27K | Buy |
15,076
+1,066
| +8% | +$1.91K | ﹤0.01% | 1745 |
|
|
2022
Q2 | $41K | Sell |
14,010
-1,697
| -11% | -$4.97K | ﹤0.01% | 1692 |
|
|
2022
Q1 | $43K | Buy |
15,707
+9,818
| +167% | +$26.9K | ﹤0.01% | 1753 |
|
|
2021
Q4 | $27K | Buy |
+5,889
| New | +$27K | ﹤0.01% | 1858 |
|
|
2021
Q2 | – | Sell |
-112,795
| Closed | -$2.49M | – | 2372 |
|
|
2021
Q1 | $2.49M | Buy |
112,795
+50,535
| +81% | +$1.12M | ﹤0.01% | 1035 |
|
|
2020
Q4 | $1.93M | Buy |
62,260
+61,926
| +18,541% | +$1.92M | ﹤0.01% | 1079 |
|
|
2020
Q3 | $7K | Buy |
+334
| New | +$7K | ﹤0.01% | 2003 |
|